The parental K562 human myelogenous leukemia cell line is a typical target to measure NK cell cytotoxicity and activation47, allowing for assessment of both NKG2A-mediated inhibition and NKG2C-mediated activation. Here, KLRC2 is linked to myeloid leukemia.